India Covid-19 Highlights: In a press briefing on the COVID-19 situation in the country, the government on Tuesday said of the total people vaccinated against COVID-19 so far, 0.18 per cent were adverse events following immunisation, while 0.002 per cent had to be hospitalised which is fairly low. Addressing a press conference, NITI Aayog member (Health) V K Paul said concerns about adverse effects and serious problems post immunisation as of now seem to be unfounded, negligible, insignificant and stressed that both the vaccines are safe. Union Health Secretary Rajesh Bhushan said India recorded the highest number of first day vaccinations for COVID-19 immunisation.
Till now 4,54,049 people have been vaccinated in India, the Health Ministry reported on Tuesday. The country reported 580 severe events and 2 persons — a 52-year-old in Moradabad & a 42-year-old in Karnataka — have reportedly died due to cardiopulmonary disease after getting their shots. The deaths have not been linked to the vaccines till now.
Centre on Monday flagged Kerala and Tamil Nadu over their poor performance, in vaccinating at less than 25 per cent of the priority groups and highlighted the “vaccine hesitancy” found in the frontline workers. Similarly, Punjab and Chhattisgarh were also pulled over their “poor coverage.”
India reported 10,064 new covid-19 cases in the last 24 hours, the lowest single day spike since second week of June. Out of the total cases, active cases further dropped to 2 lakh while recoveries went up to over 1.02 crore. With 137 deaths reported on Monday, the lowest since the May, the toll now stands at over 1.52 lakh. Kerala reported 3,346 new cases, while Maharashtra found 1,924 new infections.
Over 3.81 lakh Indians vaccinated; 2 deaths, 580 adverse events reported across the country; Daily cases below 20,000 since last 10 days. Follow this space for the latest updates on Covid-19.
India will administer shots to three crore frontline workers in phase one. There are 3,006 session sites across the country, where 100 beneficiaries each will be given either of India's two indigenous vaccines, Covaxin or Covishield. Every beneficiary will need to receive two doses of the same vaccine, 28 days apart.
On the break-up of Covishield and Covaxin, the Ministry data showed that while the first vaccine, developed by Oxford-AstraZeneca and manufactured by Pune’s Serum Institute, had been supplied to all states and Union territories, the indigenously developed Covaxin was administered in “clinical trial mode” in 12 states, including the national capital. Each session site could administer only one of the two vaccines.
During the vaccination drive, Maharashtra recorded 14 cases of adverse events, however, none of them were fatal. State officials currently studying them.
Since the pandemic hit India in early 2020, over one crore and 5.42 lakh people have been infected with the disease, while close to 1.52 lakh have died. At present, Kerala and Maharashtra are reporting the highest number of daily cases.